Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Long-term leukopenia in a lung transplanted patient with cystic fibrosis treated with zoledronic acid: a case report.

Karahasanovic A, Thorsteinsson AL, Bjarnason NH, Eiken P.

Osteoporos Int. 2016 Aug;27(8):2621-5. doi: 10.1007/s00198-016-3559-x. Epub 2016 Apr 14.

PMID:
27080707
2.

[Unexpected bronchoscopic findings in sarcoidosis].

Gottlieb M, Perch M, Santoni-Rugiu E, Arendrup MC, Bjarnason NH.

Ugeskr Laeger. 2015 Aug 17;177(34):1630. Danish. No abstract available.

PMID:
26320587
3.

Meta-analysis of routine blood tests as predictors of mortality in COPD.

Lomholt FK, Laulund AS, Bjarnason NH, Jørgensen HL, Godtfredsen NS.

Eur Clin Respir J. 2014 Jun 5;1. doi: 10.3402/ecrj.v1.24110. eCollection 2014.

4.

Dupilumab in persistent asthma.

Bjarnason NH.

N Engl J Med. 2013 Sep 26;369(13):1275. doi: 10.1056/NEJMc1309809. No abstract available.

PMID:
24066756
5.

Acute and long-term estradiol kinetics in smoking postmenopausal women.

Bjarnason NH, Jørgensen HL, Christiansen C.

Climacteric. 2012 Oct;15(5):449-54. doi: 10.3109/13697137.2011.628764. Epub 2011 Dec 23.

PMID:
22191426
6.

[Sinus thrombosis in a healthy female taking oral contraceptives].

Mogensen SS, Abild-Nielsen A, Bjarnason NH.

Ugeskr Laeger. 2011 Sep 26;173(39):2422-3. Danish.

PMID:
21958487
7.

[Intrathoracic goiter with differential diagnostic difficulties].

Scherer S, Abd-Elrahmane DG, Petersen RH, Bjarnason NH.

Ugeskr Laeger. 2009 Jan 12;171(3):147. Danish.

PMID:
19174029
8.

The effect of aromatase inhibitors on bone metabolism.

Folkestad L, Bjarnason NH, Bjerregaard JK, Brixen K.

Basic Clin Pharmacol Toxicol. 2009 Jan;104(1):3-10. doi: 10.1111/j.1742-7843.2008.00337.x. Review.

9.

The influence of smoking on bone loss and response to nasal estradiol.

Bjarnason NH, Nielsen TF, Jørgensen HL, Christiansen C.

Climacteric. 2009 Feb;12(1):59-65. doi: 10.1080/13697130802587689.

PMID:
19058059
10.

Evaluation and registration of adverse events in clinical drug trials in migraine.

Tfelt-Hansen P, Bjarnason NH, Dahlöf C, Derry S, Loder E, Massiou H; Task Force on Adverse Events in Migraine Trials of Subcommittee on Clinical Trial of International Headache Society.

Cephalalgia. 2008 Jul;28(7):683-8. doi: 10.1111/j.1468-2982.2008.01600.x. Epub 2008 May 21. Review.

PMID:
18498392
11.

Adverse bone effects during pharmacological breast cancer therapy.

Bjarnason NH, Hitz M, Jorgensen NR, Vestergaard P.

Acta Oncol. 2008;47(4):747-54. doi: 10.1080/02841860802001467. Review.

PMID:
18465344
12.

The influence of smoking on uterine bleeding during continuous and interrupted oral hormone therapy.

Bjarnason NH, Jorgensen HL, Byrjalsen I, Alexandersen P, Christiansen C.

Climacteric. 2007 Dec;10(6):480-90.

PMID:
18049941
13.

The nimorazole regimen in patients with head and neck cancer can increase the effect of vitamin K antagonists.

Bjarnason NH, Christiansen M, Specht L.

Acta Oncol. 2008;47(1):150-1. No abstract available.

PMID:
17851836
14.

COX-2 inhibitor.

Gøtzsche PC, Bjarnason NH.

Rheumatology (Oxford). 2007 Oct;46(10):1623-4; author reply 1624-5. Epub 2007 Aug 27. No abstract available.

PMID:
17726033
15.

[Effect of aromatase inhibitors on bone metabolism].

Folkestad L, Bjerregaard JK, Bjarnason NH, Brixen KT.

Ugeskr Laeger. 2007 May 7;169(19):1774-9. Review. Danish.

PMID:
17537350
16.

The influence of smoking on uterine bleeding during sequential oral hormone therapy.

Bjarnason NH, Byrjalsen I, Jørgensen HL, Christiansen C.

Climacteric. 2007 Apr;10(2):147-54.

PMID:
17453863
17.

Drug treatments for obesity.

Bjarnason NH, Blicher TM.

Lancet. 2007 Apr 7;369(9568):1163; author reply 1164. No abstract available.

PMID:
17416250
18.

Recurrent thrombophlebitis in association with CHOEP-14.

Bjarnason NH, Jurlander J, Dalhoff K.

Leuk Lymphoma. 2006 Jun;47(6):1151-2. No abstract available.

PMID:
16840210
19.

Fetal exposure to pimozide: a case report.

Bjarnason NH, Rode L, Dalhoff K.

J Reprod Med. 2006 May;51(5):443-4.

PMID:
16779996
20.

[Nephrotoxicity after the use of intravenous X-ray contrast media in a type 2 diabetic being treated with metformin].

Bjarnason NH, Elung-Jensen T.

Ugeskr Laeger. 2006 May 1;168(18):1772-3. Danish.

PMID:
16729932
21.

Optimizing lithium dosing in hemodialysis.

Bjarnason NH, Munkner R, Kampmann JP, Tornoe CW, Ladefoged S, Dalhoff K.

Ther Drug Monit. 2006 Apr;28(2):262-6.

PMID:
16628141
22.

[Gunnar Lose a good example].

Bjarnason NH, Lindberg M, Lunde IM.

Ugeskr Laeger. 2006 Mar 6;168(10):1045-6. Danish. No abstract available.

PMID:
16522306
23.

[The clausulation for gabapentin and pregabalin was not used in accordance to the rules].

Bjarnason NH, Laursen N.

Ugeskr Laeger. 2006 Feb 20;168(8):811; author reply 811-2. Danish. No abstract available.

PMID:
16499858
24.

[What is necessary to archive when one writes a case report?].

Bjarnason NH, Bach KF.

Ugeskr Laeger. 2006 Jan 3;168(1):78-9. Danish. No abstract available.

PMID:
16393578
25.

Drug metabolism and variability.

Bjarnason NH.

N Engl J Med. 2005 Sep 1;353(9):955-6; author reply 955-6. No abstract available.

PMID:
16135846
26.

Endometrial cancer and hormone-replacement therapy.

Bjarnason NH.

Lancet. 2005 Jul 16-22;366(9481):200-1. No abstract available.

PMID:
16023503
27.

Differential effects of alternatives to hormone replacement therapy in postmenopausal healthy women.

Bjarnason NH.

Dan Med Bull. 2005 May;52(2):64-81. No abstract available.

PMID:
16009050
28.

Inconsistency in the editorial process in Archives of Internal Medicine?

Bjarnason NH.

Arch Intern Med. 2005 Jun 27;165(12):1439-40; author reply 1440; discussion 1440. No abstract available.

PMID:
15983298
29.

Smoking reduces breast tenderness during oral estrogen-progestogen therapy.

Bjarnason NH, Jørgensen C, Kremmer H, Alexandersen P, Christiansen C.

Climacteric. 2004 Dec;7(4):390-6.

PMID:
15799610
30.

Nimorazole may increase the effect of phenprocoumon.

Bjarnason NH, Specht L, Dalhoff K.

Radiother Oncol. 2005 Mar;74(3):345. Epub 2004 Nov 25. No abstract available.

PMID:
15763317
31.

Medicare drug beneficiaries and cost-lowering strategies.

Bjarnason NH, Kampmann JP.

JAMA. 2005 Feb 2;293(5):552-3; author reply 553. No abstract available.

PMID:
15687306
32.

Disparities in participation in cancer clinical trials.

Bjarnason NH.

JAMA. 2004 Aug 25;292(8):922; author reply 922-3. No abstract available.

PMID:
15328321
33.

Ten years of alendronate treatment for osteoporosis in postmenopausal women.

Bjarnason NH.

N Engl J Med. 2004 Jul 8;351(2):190-2; author reply 190-2. No abstract available.

PMID:
15247362
34.

Associated response in bone and lipids during hormone replacement therapy.

Thomsen AB, Silvestri S, Haarbo J, Christiansen C, Bjarnason NH.

Maturitas. 2004 Jan 20;47(1):39-45.

PMID:
14706764
35.

Role of gastrointestinal hormones in postprandial reduction of bone resorption.

Henriksen DB, Alexandersen P, Bjarnason NH, Vilsbøll T, Hartmann B, Henriksen EE, Byrjalsen I, Krarup T, Holst JJ, Christiansen C.

J Bone Miner Res. 2003 Dec;18(12):2180-9.

36.

Bisphosphonates in children with bone diseases.

Bjarnason NH.

N Engl J Med. 2003 Nov 20;349(21):2068-71; author reply 2068-71. No abstract available.

PMID:
14631923
37.

Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.

Jolly EE, Bjarnason NH, Neven P, Plouffe L Jr, Johnston CC Jr, Watts SD, Arnaud CD, Mason TM, Crans G, Akers R, Draper MW.

Menopause. 2003 Jul-Aug;10(4):337-44.

PMID:
12851517
38.
39.

Selection bias introduced by the informed consent process.

Bjarnason NH, Kampmann JP.

Lancet. 2003 Jun 7;361(9373):1990. No abstract available.

PMID:
12801770
40.
41.

Postmenopausal bone remodelling and hormone replacement.

Bjarnason NH, Hassager C, Christiansen C.

Climacteric. 1998 Mar;1(1):72-9. Review.

PMID:
11907930
42.
43.

Mechanism of circadian variation in bone resorption.

Bjarnason NH, Henriksen EE, Alexandersen P, Christgau S, Henriksen DB, Christiansen C.

Bone. 2002 Jan;30(1):307-13.

PMID:
11792602
44.

The effect of fluvastatin on parameters of bone remodeling.

Bjarnason NH, Riis BJ, Christiansen C.

Osteoporos Int. 2001;12(5):380-4.

PMID:
11444086
45.

How does quantitative ultrasound compare to dual X-ray absorptiometry at various skeletal sites in relation to the WHO diagnosis categories?

Jørgensen HL, Warming L, Bjarnason NH, Andersen PB, Hassager C.

Clin Physiol. 2001 Jan;21(1):51-9.

PMID:
11168297
46.

Raloxifene and estrogen reduces progression of advanced atherosclerosis--a study in ovariectomized, cholesterol-fed rabbits.

Bjarnason NH, Haarbo J, Byrjalsen I, Alexandersen P, Kauffman RF, Christiansen C.

Atherosclerosis. 2001 Jan;154(1):97-102.

PMID:
11137087
47.

Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials.

Johnston CC Jr, Bjarnason NH, Cohen FJ, Shah A, Lindsay R, Mitlak BH, Huster W, Draper MW, Harper KD, Heath H 3rd, Gennari C, Christiansen C, Arnaud CD, Delmas PD.

Arch Intern Med. 2000 Dec 11-25;160(22):3444-50.

PMID:
11112238
48.

Low doses of estradiol in combination with gestodene to prevent early postmenopausal bone loss.

Bjarnason NH, Byrjalsen I, Hassager C, Haarbo J, Christiansen C.

Am J Obstet Gynecol. 2000 Sep;183(3):550-60.

PMID:
10992173
49.

Digital X-ray radiogrammetry: a new appendicular bone densitometric method with high precision.

Jørgensen JT, Andersen PB, Rosholm A, Bjarnason NH.

Clin Physiol. 2000 Sep;20(5):330-5.

PMID:
10971543

Supplemental Content

Loading ...
Support Center